Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7M Buy
+66,841
New +$9.24M 0.41% 58
2019
Q3
– Sell
-2,830
Closed -$226K – 87
2019
Q2
$226K Hold
2,830
– – 0.02% 89
2019
Q1
$225K Hold
2,830
– – 0.02% 106
2018
Q4
$206K Buy
+2,830
New +$200K 0.02% 90
2016
Q4
– Sell
-9,353
Closed -$557K – 112
2016
Q3
$557K Hold
9,353
– – 0.09% 105
2016
Q2
$514K Hold
9,353
– – 0.09% 105
2016
Q1
$472K Buy
+9,353
New +$458K 0.09% 105
2015
Q4
– Sell
-6,760
Closed -$319K – 115
2015
Q3
$319K Sell
6,760
-2,730
-29% -$145K 0.06% 102
2015
Q2
$516K Buy
+9,490
New +$532K 0.08% 90

Other funds holding MRK

NS Partners's MRK Position: Q3 2026 in Review

NS Partners opened a new position in Merck (MRK) in Q3 2026: 66,841 shares worth $9.7M. The stake represents 0.41% of the portfolio and ranks #58 among its holdings. This is a return to the name: NS Partners previously reported a position in MRK as recently as Q2 2019.

NS Partners first reported a position in MRK in Q2 2015 and has held it in 9 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • NS Partners held 66,841 shares of Merck worth $9.7M as of Q3 2026.
  • Merck was a new NS Partners position in Q3 2026.
  • Merck made up 0.41% of NS Partners's portfolio in Q3 2026, its #58 holding.
  • NS Partners first reported a position in Merck in Q2 2015 and has held it in 9 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on NS Partners's 13F filing for Q3 2026, filed 10 Nov 2026.